the relationship between psychiatry and pharmaceutical companies has come under scrutiny during the past decadeconcerns are growing that financial ties of psychiatrists to the pharmaceutical industry may unduly influence professional judgments involving the primary interests of patientssuch conflicts of interest threaten the public trust in psychiatrythe goal of conflict of interest policies is to protect the integrity of professional judgment and to preserve public trustthe disclosure of individual and institutional financial relationships is a critical but limited first step in the process of identifying and responding to conflicts of interestconflict of interest policies and procedures can be strengthened by engaged psychiatrists researchers institutions and professional associations in developing policies and consensus standardsresearch on conflicts of interest can provide a stronger evidence base for policy design and implementationsociety has traditionally granted the medical profession considerable autonomy and may be willing to continue do so in the case of conflicts of interestnevertheless concern is growing that stronger measures are neededto avoid undue regulatory burdens psychiatrists can play a vital role in designing responsible and reasonable conflict of interest policies that reduce the risks of bias and the loss of trustpsychiatrists and the institutions that carry out research education clinical care and practice guideline development must recognize public concerns about conflicts of interest and take effective measures soon to maintain public trust with a cultural change in the practice of psychiatry from reactive treatmentseeking for mental illness to proactive advocacy for patients 2014 the authorspsychiatry and clinical neurosciences  2014 japanese society of psychiatry and neurology